arrow
D

Diana Ballhausen

pediatric metabolic unit
H指数:30
被引数:4,474

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Fibroblast Transcriptomics in Molecular Diagnostics of a Comprehensive Dystonia Cohort

成纤维细胞转录组学在综合肌张力障碍队列分子诊断中的应用

2026-02-020
OAAI
Correspondence on “Phenylalanine hydroxylase deficiency diagnosis and management: A 2023 evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG)” by Smith et al

关于“苯丙氨酸羟化酶缺乏症的诊断与管理:美国医学遗传学与基因组学学院(ACMG)2023年循证临床指南”的通信,由Smith等人撰写

2026-01-060
PRE
De novo variants in RNF213 are associated with a clinical spectrum ranging from Leigh syndrome to early-onset stroke

RNF213的De novo变异与从Leigh综合征到早发性中风的临床范围相关

2024-02-015
PRE
Efficacy and safety of empagliflozin in glycogen storage disease type Ib: Data from an international questionnaire

依格列净治疗Ib型糖原贮积病的疗效和安全性: 来自国际问卷的数据

2022-08-0140
OA
Heterozygous variants in CTR9, which encodes a major component of the PAF1 complex, are associated with a neurodevelopmental disorder

编码PAF1复合体主要成分的CTR9杂合变异与神经发育障碍相关

2022-07-013
OAAI
Active site variants in STT3A cause a dominant type I congenital disorder of glycosylation with neuromusculoskeletal findings
2021-11-017
OAAI
The first knock-in rat model for glutaric aciduria type I allows further insights into pathophysiology in brain and periphery
2021-06-0124
OAAI
Expanding the clinical and genetic spectrum of CAD deficiency: an epileptic encephalopathy treatable with uridine supplementation
2020-10-0124
OAAI
An immune tolerance approach using methotrexate in the naive setting of patients treated with a therapeutic protein: Experience in infantile Pompe disease
2018-02-011
PREAI
Prophylactic immune modulation in infantile Pompe disease using low-dose methotrexate induction: A safe, inexpensive, widely accessible, and efficacious strategy
2016-02-015
PREAI